Franklin Resources’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$35.9M Buy
489,340
+156,248
+47% +$11.5M 0.01% 732
2025
Q1
$38M Buy
333,092
+59,118
+22% +$6.75M 0.01% 694
2024
Q4
$13.8M Buy
273,974
+31,183
+13% +$1.57M ﹤0.01% 1012
2024
Q3
$11M Buy
242,791
+2,475
+1% +$112K ﹤0.01% 1086
2024
Q2
$7.81M Sell
240,316
-5,146
-2% -$167K ﹤0.01% 1157
2024
Q1
$6.18M Buy
245,462
+17,877
+8% +$450K ﹤0.01% 1246
2023
Q4
$7.39M Buy
227,585
+4,471
+2% +$145K ﹤0.01% 1013
2023
Q3
$6.08M Sell
223,114
-20,704
-8% -$564K ﹤0.01% 1032
2023
Q2
$5.42M Buy
243,818
+20,647
+9% +$459K ﹤0.01% 1088
2023
Q1
$4.83M Sell
223,171
-15,944
-7% -$345K ﹤0.01% 1098
2022
Q4
$4.86M Sell
239,115
-15,226
-6% -$309K ﹤0.01% 1115
2022
Q3
$6.52M Buy
254,341
+46
+0% +$1.18K ﹤0.01% 1034
2022
Q2
$6.05M Buy
+254,295
New +$6.05M ﹤0.01% 1065